Cargando…
Enzyme replacement therapy in two patients with classic Fabry disease from the same family tree: Two case reports
BACKGROUND: The pathophysiology of Fabry disease (FD)-induced progressive vital organ damage is irreversible. Disease progression can be delayed using enzyme replacement therapy (ERT). In patients with classic FD, sporadic accumulation of globotriaosylceramide (GL-3) in the heart and kidney begins i...
Autores principales: | Harigane, Yuki, Morimoto, Issei, Suzuki, O, Temmoku, Jumpei, Sakamoto, Takayuki, Nakamura, Kohichiro, Machii, Kazuo, Miyata, Masayuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10294186/ https://www.ncbi.nlm.nih.gov/pubmed/37383915 http://dx.doi.org/10.12998/wjcc.v11.i15.3542 |
Ejemplares similares
-
Different renal phenotypes in related adult males with Fabry disease with the same classic genotype
por: Mignani, Renzo, et al.
Publicado: (2017) -
First two years of reimbursed enzyme replacement therapy in the treatment of Fabry disease in Poland
por: Nowicki, Michał, et al.
Publicado: (2021) -
Early initiation of enzyme replacement therapy in classical Fabry disease normalizes biomarkers in clinically asymptomatic pediatric patients
por: Kritzer, Amy, et al.
Publicado: (2019) -
Metabolic progression to clinical phenotype in classic Fabry disease
por: Spada, Marco, et al.
Publicado: (2017) -
Early Renal Involvement in a Girl with Classic Fabry Disease
por: Perretta, Fernando, et al.
Publicado: (2017)